title: Toll-like receptor-4 and lipoprotein accumulation in macrophages.
abstract: Excessive lipid accumulation in macrophages, also known as foam cell formation, is a key process during the development of atherosclerosis, leading to vascular inflammation and plaque growth. Recent studies have identified a new mechanism of macrophage lipid accumulation in which minimally oxidized low-density lipoprotein (mmLDL) and its active components, polyoxygenated cholesteryl ester hydroperoxides, are involved in endogenous activation of toll-like receptor-4 (TLR4), leading to recruitment of spleen tyrosine kinase (Syk), robust cytoskeletal rearrangements and macropinocytosis. In hyperlipidemic environments, mmLDL-induced, TLR4- and Syk-dependent macropinocytosis leads to substantial lipid accumulation in macrophages and monocytes, which may constitute an important mechanism of foam cell formation in atherosclerosis. A novel hypercholesterolemic zebrafish model of early stages of atherosclerosis was used to demonstrate that the TLR4 deficiency significantly reduces the in vivo rate of macrophage lipid accumulation in vascular lesions.
authors.affiliation: Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. yumiller@ucsd.edu <yumiller@ucsd.edu>
authors.forename: Yury I
authors.initials: YI
authors.lastname: Miller
authors.forename: Soo-Ho
authors.initials: SH
authors.lastname: Choi
authors.forename: Longhou
authors.initials: L
authors.lastname: Fang
authors.forename: Richard
authors.initials: R
authors.lastname: Harkewicz
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000473:pathology; D002788:Cholesterol Esters / Q000378:metabolism; D005487:Foam Cells / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism* / Q000502:physiology; D008264:Macrophages / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D008954:Models, Biological; D051197:Toll-Like Receptor 4 / Q000378:metabolism*; D015027:Zebrafish
chemical_list: D002788:Cholesterol Esters; D008077:Lipoproteins, LDL; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4
references.citation: Trends Cardiovasc Med. 2004 Jul;14(5):191-5
references.pmid: 15261891
references.citation: Atherosclerosis. 2003 Sep;170(1):187-90
references.pmid: 12957699
references.citation: Circ Res. 2009 Apr 24;104(8):952-60
references.pmid: 19265037
references.citation: J Exp Med. 2008 Feb 18;205(2):373-83
references.pmid: 18250194
references.citation: Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):e61-4
references.pmid: 14563652
references.citation: N Engl J Med. 2002 Jul 18;347(3):185-92
references.pmid: 12124407
references.citation: Biochem Biophys Res Commun. 2005 Dec 9;338(1):128-35
references.pmid: 16105647
references.citation: J Clin Invest. 2005 Aug;115(8):2072-5
references.pmid: 16075051
references.citation: J Biol Chem. 2003 Jan 17;278(3):1561-8
references.pmid: 12424240
references.citation: Circulation. 2005 May 24;111(20):2654-61
references.pmid: 15883205
references.citation: Clin Exp Immunol. 2006 Feb;143(2):269-73
references.pmid: 16412050
references.citation: Curr Drug Targets. 2007 Dec;8(12):1249-63
references.pmid: 18220702
references.citation: FASEB J. 2008 Oct;22(10):3595-606
references.pmid: 18559988
references.citation: J Neurol. 2004 Jul;251(7):853-8
references.pmid: 15258789
references.citation: J Biol Chem. 2006 Jun 9;281(23):15757-62
references.pmid: 16606620
references.citation: Mol Aspects Med. 2003 Aug-Oct;24(4-5):239-50
references.pmid: 12893002
references.citation: J Biol Chem. 2008 Apr 18;283(16):10241-51
references.pmid: 18263582
references.citation: J Lipid Res. 2009 Apr;50 Suppl:S388-93
references.pmid: 19106070
references.citation: J Biol Chem. 2005 Jan 21;280(3):2352-60
references.pmid: 15533943
references.citation: Biochim Biophys Acta. 1992 Oct 30;1128(2-3):117-31
references.pmid: 1420284
references.citation: BMC Med Genomics. 2008 Nov 28;1:60
references.pmid: 19040724
references.citation: Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2384-91
references.pmid: 17872459
references.citation: Circulation. 2007 Oct 16;116(16):1832-44
references.pmid: 17938300
references.citation: Circ Res. 2009 Jun 19;104(12):1355-63
references.pmid: 19461045
references.citation: Nat Med. 2004 Apr;10(4):416-21
references.pmid: 15034566
references.citation: Pharmacogenet Genomics. 2005 Jan;15(1):15-21
references.pmid: 15864121
references.citation: Arteriosclerosis. 1984 Jul-Aug;4(4):323-40
references.pmid: 6466191
references.citation: Circulation. 2004 Oct 5;110(14):2024-31
references.pmid: 15451785
references.citation: Eur J Clin Invest. 2004 Feb;34(2):94-9
references.pmid: 14764071
references.citation: J Lipid Res. 1995 Sep;36(9):1996-2004
references.pmid: 8558087
references.citation: Circ Res. 2009 Jan 30;104(2):210-8, 21p following 218
references.pmid: 19096031
references.citation: Mol Biol Cell. 2003 Oct;14(10):4196-206
references.pmid: 14517329
references.citation: Am J Pathol. 2002 Feb;160(2):701-10
references.pmid: 11839591
references.citation: Curr Opin Lipidol. 2003 Oct;14(5):437-45
references.pmid: 14501582
references.citation: Circulation. 2001 Dec 18;104(25):3103-8
references.pmid: 11748108
references.citation: Circulation. 2003 May 20;107(19):2416-21
references.pmid: 12742999
references.citation: J Biol Chem. 2009 Jul 31;284(31):21077-89
references.pmid: 19509298
references.citation: Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1213-9
references.pmid: 15718493
references.citation: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10679-84
references.pmid: 15249654